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Reza Nezafat, PHD,* Beth Goddu, RT(R)(MR),* Kraig V. Kissinger, RT(R)(MR),*
Peter J. Zimetbaum, MD,* Warren J. Manning, MD,*† Susan B. Yeon, MD, JD*
Boston, Massachusetts
O B J E C T I V E S This study sought to develop cardiovascular magnetic resonance (CMR) diagnostic
criteria for mitral valve prolapse (MVP) using echocardiography as the gold standard and to characterize
MVP using cine CMR and late gadolinium enhancement (LGE)-CMR.
B A C KG ROUND Mitral valve prolapse is a common valvular heart disease with signiﬁcant
complications. Cardiovascular magnetic resonance is a valuable imaging tool for assessing ventricular
function, quantifying regurgitant lesions, and identifying ﬁbrosis, but its potential role in evaluating MVP
has not been deﬁned.
METHOD S To develop CMR diagnostic criteria for MVP, characterize mitral valve morphology, we
analyzed transthoracic echocardiography and cine CMR images from 25 MVP patients and 25 control
subjects. Leaﬂet thickness, length, mitral annular diameters, and prolapsed distance were measured.
Two- and three-dimensional LGE-CMR images were obtained in 16 MVP and 10 control patients to
identify myocardial regions of ﬁbrosis in MVP.
R E S U L T S We found that a 2-mm threshold for leaﬂet excursion into the left atrium in the left
ventricular outﬂow tract long-axis view yielded 100% sensitivity and 100% speciﬁcity for CMR using
transthoracic echocardiography as the clinical gold standard. Compared with control subjects, CMR
identiﬁed MVP patients as having thicker (3.2 0.1 mm vs. 2.3 0.1 mm) and longer (10.5 0.5 mm/m2
vs. 7.1  0.3 mm/m2) indexed posterior leaﬂets and larger indexed mitral annular diameters (27.8  0.7
mm/m2 vs. 21.5  0.5 mm/m2 for long axis and 22.9 0.7 mm/m2 vs. 17.8  0.6 mm/m2 for short axis).
In addition, we identiﬁed focal regions of LGE in the papillary muscles suggestive of ﬁbrosis in 10 (63%)
of 16 MVP patients and in 0 of 10 control subjects. Papillary muscle LGE was associated with the
presence of complex ventricular arrhythmias in MVP patients.
CONC L U S I O N S Cardiovascular magnetic resonance image can identify MVP by the same
echocardiographic criteria and can identify myocardial ﬁbrosis involving the papillary muscle in MVP
patients. Hyperenhancement of papillary muscles on LGE is often present in a subgroup of patients with
complex ventricular arrhythmias. (J Am Coll Cardiol Img 2008;1:294–303) © 2008 by the American
College of Cardiology Foundation
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295itral valve prolapse (MVP) is a common
disorder afflicting 2% to 3% of the
general population and is the most
common cause of severe nonischemic
itral regurgitation (MR) requiring surgery in the
.S. (1). Mitral valve prolapse is defined by echo-
ardiography as a condition in which segment(s) of
or both mitral leaflets extend above the plane of
he mitral annulus in the parasternal long-axis view
uring ventricular systole by at least 2 mm (2,3).
See page 304
Mitral valve prolapse has been extensively studied
y echocardiography, including two-dimensional
2D) and three-dimensional (3D) transthoracic echo-
ardiography (TTE) and transesophageal echocardi-
graphy (2–7). Transthoracic echocardiography re-
ains the diagnostic modality of choice for MVP
ecause of its ease of use and unsurpassed temporal
esolution. However, TTE imaging is highly depen-
ent on patient image windows and the MR assess-
ent is limited by its semiquantitative nature. Three-
imensional TTE provides excellent visualization of
he prolapsed leaflets, but the limitations of echocar-
iography remain. Cardiovascular magnetic resonance
CMR) is a noninvasive imaging method with unlim-
ted imaging planes that provides reproducible quan-
itative data on cardiac anatomy and function (8,9).
ine CMR methods allow for characterization of the
alve morphology, and velocity encoded CMR pro-
ides for quantification of MR (10–12). In addition,
MR also provides a method to assess myocardial
brosis. A recent study (13) compared cine CMR
ssessment of mitral valve morphology to transesoph-
geal echocardiography and surgical findings, but the
riteria for MVP in CMR was not developed.
Major complications such as progressive MR re-
uiring valvular surgery and ventricular arrhythmia
nd sudden death are predominantly associated with
he subgroup of patients with myxomatous valves
14,15), which are characterized by diffuse leaflet
hickening, elongation, redundancy, and in some cases
uptured chordae tendineae (16). These characteristics
f the mitral valve leaflets would be important to
ssess in MVP patients. In the patients who ultimately
o to surgery, pre-operative characterization of pro-
apsed scallops (according to the Carpentier classifica-
ion [17]) has significant implications for the com-
lexity of surgical repair because the repair rates are
ower in anterior leaflet prolapse (18–20). Trans-
sophageal echocardiography is usually used for reli-
ble scallop assessment; however, due to its moder- dtely invasive nature, it is not universally performed
rior to surgery. Because CMR is capable of imaging
n multiple planes, it may reliably visualize individual
callops noninvasively.
The increased risk of atrial and ventricular tachy-
rrhythmias in myxomatous MVP patients can be
s high as 50% to 60%, and there is a risk (0.4% to
% per year) of sudden death in these patients
15,21,22). The relevance of these arrhythmias to
he risk of sudden death remains uncertain. A
umber of young sudden death victims with MVP
re asymptomatic females without significant MR
23,24). Perivalvular ventricular fibrosis and papil-
ary muscle fibrosis have been well described in
athological studies (23,25). Additional
eports have described scarring of the pap-
llary muscles attributed to abnormal ten-
ion and subsequent ischemia of papillary
uscles (26). Perivalvular and papillary
uscle fibrosis in MVP patients has not
een assessed in vivo and its relationship
o ventricular tachyarrhythmias has not
een examined.
We sought to develop CMR diagnostic
riteria for MVP, characterize mitral valve
orphology, and use 3D high-resolution
ate gadolinium enhancement (LGE)-
MR imaging (27) to visualize regions of
yocardium with characteristics sugges-
ive of fibrosis in MVP patients.
E T H O D S
atient selection. A query of our clinical
TE and CMR database identified 24
atients from 2004 to 2006 with CMR
nd TTE studies within 12 months of
ach other. Data from 12 patients were
xcluded due to prior mitral valve surgery
2), other coexisting valvular disease (3) or
eart disease (3), or poor TTE (3) or CMR (1)
mages. A total of 19 patients with MVP were
rospectively enrolled in an institutional review
oard–approved protocol (5 patients) or referred by
heir cardiologists to undergo CMR under clinical
ndications (14 patients). Of the 19 patients, 6 were
xcluded from valve morphology analysis due to
ack of TTE (3) or poor CMR (2) images or were
ncluded in the retrospective arm (1). All prospec-
ively imaged MVP patients had no history of
oronary artery disease, hypertension, diabetes, or
ther intrinsic cardiomyopathies. We selected a
ontrol group of 25 patients with absence of valvular
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296rospective patients, 3 with no (1) or poor (2)
igh-resolution 3D LGE-CMR were excluded in
GE analysis. Of the 25 control patients, 2 had
igh-resolution 3D LGE-CMR performed. An
dditional 8 normal control patients who had 3D
GE-CMR were included in LGE analysis.
chocardiography. Transthoracic 2D and Doppler
chocardiographic examinations were performed
ith a 3.5-MHz probe on a Vivid 7 ultrasono-
raphic unit (GE Vingmed Ultrasound AS,
orten, Norway). Parasternal long-axis, apical
-chamber (4C), and 2-chamber (2C) views were
btained as part of the routine clinical assessment.
MR. The CMR imaging was performed using an
chieva 1.5-T MR whole body scanner (Philips
edical Systems, Best, the Netherlands) equipped
ith a 5-element cardiac synergy coil. Breath-hold
etrospectively electrocardiogram (ECG)-gated
ine steady state free processing (SSFP) images
ere acquired in the 2C and 4C horizontal long-
xis views, and a short axis stack covering the entire
eft ventricle (8-mm slices with 2-mm gaps) as
reviously described (8,9). The left ventricular out-
ow tract (LVOT) long-axis view (Fig. 1), equiva-
ent to the TTE parasternal long-axis view, was
btained by prescribing an image plane perpendic-
lar to the mitral annular major axis centered at the
ortic outflow track. In prospectively imaged MVP
atients, a stack of cine SSFP images with 7-mm
lice thickness with no gap in the LVOT view were
btained to cover the entire mitral valve (Fig. 2A).
equence parameters were repetition time 3 ms,
Figure 1. Comparison of the Long-Axis View in Control and MV
Control (A to D) and mitral valve prolapse (MVP) (E to H) patients.
long-axis views (A, B, E, F) and cardiovascular magnetic resonance
Diastole; (B, D, F, H) systole. In panel H, arrows indicate the prolap
leaﬂet to the mitral annular plane. LA  left atrium.cho time 1.5 ms, flip angle 60°, field-of-view 320
m, matrix 160  160. Temporal resolution was
0 to 35 ms. Free-breathing, ECG-triggered phase
ontrast velocity sequences for aortic flow oriented
n the axial plane at the level of the bifurcation of
he pulmonary artery were acquired as previously
escribed (12).
Fifteen minutes after 0.2 mmol/kg intravenous
dministration of gadolinium-diethylenetriamine
enta-acetic acid (Magnevist, Berlex/Schering AG,
erlin, Germany), ECG-gated breath-hold 2D
GE-CMR was performed in the 2C, 4C, and
hort axis orientations corresponding to the SSFP
ine slices as previously described (28). Scan param-
ters were repetition time 4.3 ms, echo time 2.1 ms,
ip angle 15°, field-of-view 320 mm, matrix 160 
60, spatial resolution 2  2  8 mm3 recon-
tructed to 1.2  1.2  8 mm3 using zero-padding.
t 20 min after injection, an ECG-gated free
reathing, respiratory navigator-gated 3D LGE-
MR scan was obtained as previously described
27). Scan parameters were repetition time 5.6 ms,
cho time 2.7 ms, flip angle 25°, field-of-view 320
m, full echo, matrix 224  224  23 to 32
artition-encoded lines, spatial resolution 1.3  1.3
5 mm3 reconstructed to 0.6  0.6  2.5 mm3.
or both 2D and 3D LGE-CMR scans, fat satu-
ation was applied and inversion times were deter-
ined using the Look-Locker sequence (29).
mage analysis. The TTE image analysis was per-
ormed by a blinded experienced observer (DB) on
choPACS Dimension (BT06, GE Vingmed Ul-
tients by TTE and CMR
two-dimensional transthoracic echocardiography (TTE) parasternal
R) left ventricle (LV) outﬂow tract views (C, D, G, H). (A, C, E, G)
distance measured by the maximum distance of the prolapsedP Pa
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297rasound AS, Horten, Norway). The CMR data
ere analyzed independently by a different blinded
bserver (C.J.S.) using VIEWFORUM (Release 4)
oftware (Philips Medical Systems). For both TTE
nd CMR, the prolapsed distance was measured for
ach leaflet as the maximum excursion of the leaflet
eyond the mitral annular plane as defined by a line
onnecting the inferolateral mitral annulus to the
ortomitral junction during systole (Fig. 1H). Ad-
itional measurements performed included the di-
stolic maximum mitral leaflet thickness (Fig. 3A),
ength (Fig. 4A), and end-systolic mitral annular
Figure 2. The LVOT Stack Prescription and 2 Examples
(A) Left ventricular outﬂow tract (LVOT) stack prescription is created
the long axis of the valve. (B) The LVOT stack from a patient with A
(C) The LVOT stack from a patient with prolapse of all scallops and
valve; PA  pulmonary artery; RA  right atrium.
Figure 3. Mitral Leaﬂet Thickness
(A) The LVOT view showing leaﬂet thickness measurements obtaine
leaﬂets (including both anterior and posterior) by CMR versus TTE.
are generally higher than the CMR measurements. Abbreviations as in Fiameter (MAD). The greater of the 2C and 4C
AD was used to approximate the major MAD
Fig. 5A). The TTE end-systolic parasternal long-
xis MAD or the CMR LVOT MAD were used to
pproximate the minor MAD (Fig. 5B). Mitral
eaflet length and MAD were indexed to body
urface area. The blood-to-leaflet contrast ratio was
easured by obtaining the ratio of maximum and
inimum signal intensity across the valve leaflet
uring diastole. The ejection fraction (EF) was
alculated by tracing the end-diastolic and end-
ystolic left ventricular (LV) slice contours and
obtaining parallel slices across the mitral valve perpendicular to
1, A2, and P2 prolapses. (i) A1/P1, (ii) and (iii) A2/P2, (iv) A3/P3.
ntrally directed mitral regurgitation jet. Ao  aorta; MV  mitral
the thickest portion of the leaﬂet during diastole. (B) Plot of all
) Linear regression as described in text. The TTE measurementsby
1, P
a ced at
(Lineigures 1 and 2.
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298Figure 4. Indexed Mitral Leaﬂet Lengths
(A) The LVOT view showing both leaﬂet length measurements in diastole. (B) Plot of CMR versus TTE indexed leaﬂet length
(including both anterior and posterior). (Line) Linear regression as described in text. Abbreviations as in Figures 1 and 2.Figure 5. Indexed MADs
(A) The 2- and 4-chamber views of the end-systolic long-axis mitral annular diameter (MAD) measurement. (B) The LVOT view
of the end-systolic short axis MAD measurement. (C) Plot of CMR versus TTE indexed MAD (including both long- and short-axis).
(Line) Linear regression as described in text. Abbreviations as in Figures 1 and 2.
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299sing the modified Simpson’s rule method. The
R fraction was calculated as the difference be-
ween LV stroke volume and the forward aortic
ow volume divided by the LV stroke volume (12).
The presence of abnormal LGE of the mitral valve
as determined by the presence of extensive partial to
omplete ring-shaped high signal intensity (defined as
 standard deviations higher than remote myocar-
ium) in the short axis valve plane. Myocardial LGE
as considered positive when part of the myocardial
issue present on the SSFP images was replaced by
igh signal intensity in the LGE images.
rrhythmia analysis. Complex ventricular arrhyth-
ia (CVA) was defined as Grade III or higher by
he Lown and Wolf classification (30). Absence of
VA was determined by a negative Holter or event
onitor, or by the absence of complaints of palpi-
ations or skipped beats and no ambulatory ECG
ecord of ventricular arrhythmias while being regu-
arly followed by local cardiologists for at least 5
ears.
tatistical analysis. Data are presented as mean 
tandard deviation (for age, body surface area, and
F) or mean  standard error of the mean (for
easurements presented in Table 4). The sensitiv-
ty and the specificity of CMR identification of
rolapse were determined using TTE as the gold
tandard. Data were analyzed using the 2-tailed
tudent’s t test to compare continuous variables
uch as EF, body surface area, and age; the Wil-
oxon rank sum test was used to compare categor-
cal variables such as MR grade and gender. Fisher’s
xact test was used to test the relationship between
GE and CVA. Linear regression analyses were
erformed between CMR and TTE measurements.
Table 1. Patient Characteristics for Mitral Valve Morphology
Control (n  25) MVP (n  25) p Value
Age (yrs) 42.8 11.0 50.9 12.0 0.02
Male (%) 12 (48) 15 (60) 0.40
BSA (m2) 1.87 0.29 1.85 0.20 0.80
EF (%) 60.8 5.5 65.6 6.7 0.01
MR
0 18 0
1 7 2
2 0 4
3 0 14
4 0 5
Values are mean  standard deviation.
BSA  body surface area; EF  ejection fraction; MR  mitral regurgitation;
MVP  mitral valve prolapse. p value of 0.05 was considered significant. Alltatistical analyses were performed with STATA
ersion 10 (StataCorp, College Station, Texas).
E S U L T S
itral valve morphology. The clinical characteristics
f the MVP and control populations for mitral
alve morphology analyses are summarized in Table
. Gender and body surface area distributions were
imilar. The MVP cohort on average was slightly
lder and had a higher EF. Figure 1 demonstrates
TE and CMR images of a control subject and a
VP subject in the long-axis view during diastole
nd systole. The sensitivity and specificity for leaflet
dentification and MVP patient identification using
-, 2-, and 3-mm leaflet displacements beyond the
itral annulus as cutoffs are summarized in Table 2.
sing the criterion of at least 2-mm displacement,
MR had 100% sensitivity and specificity in iden-
ifying MVP patients (all 25 MVP patients cor-
ectly identified). On a per leaflet basis, the 2-mm
riterion had 100% sensitivity and specificity for the
osterior leaflet; the sensitivity was 78% and spec-
ficity was 97% for the anterior leaflet.
dentiﬁcation of prolapsed scallops. By choosing a
tack of cine SSFP images (Fig. 2A) perpendicular
o the mitral valve major axis in the LVOT view, we
an identify prolapsed scallops. Figure 2B shows an
mage from a patient with prolapse of 4 scallops on
MR (A1, A2, P1, and P2, but not A3 and P3),
nd Figure 2C shows an image from a patient with
rolapse of all scallops and centrally directed MR
et. Cine images of this mitral valve can be seen in
he Online Video.
omparison of leaﬂet thicknesses. Measurements of
eaflet thickness of MVP and control subjects by
TE and CMR are presented in Table 3. The
MR measurements of the posterior leaflet were
Table 2. Sensitivity and Speciﬁcity of CMR Diagnostic Criterion
of MVP Using Cutoffs of 1 mm, 2 mm, or 3 mm of Leaﬂet
Excursion Into the Left Atrium Beyond the Mitral Annulus
1 mm (%) 2 mm (%) 3 mm (%)
Anterior leaﬂet
Sensitivity 83 78 67
Speciﬁcity 90 97 97
Posterior leaﬂet
Sensitivity 100 100 96
Speciﬁcity 100 100 100
Any leaﬂet
Sensitivity 100 100 96
Speciﬁcity 96 100 100CMR  cardiovascular magnetic resonance; other abbreviations as in Table 1.
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300ignificantly greater in the MVP patients as com-
ared to the control subjects. We did not find the
nterior leaflet thickness measurements to be sig-
ificantly different by CMR in MVP patients as
ompared to controls, but the significant difference
as found by TTE. Linear regression gave a best fit
s CMR leaflet thickness  2.3 mm  0.16 
TE leaflet thickness, with R2  0.153, as shown
n Figure 3B. There was significantly higher blood-
o-leaflet contrast ratio of the leaflets from MVP
atients compared to control patients by CMR (p
 0.002) (Table 3).
omparison of leaﬂet lengths. The MVP patients
ad longer indexed posterior leaflets by both CMR
nd TTE, but we did not find the indexed anterior
eaflet length to be significantly different from that
f the control patients (Table 3). Linear regression
LGE
steady state free processing (SSFP) and late gadolinium enhance-
the short axis valve plane. In LGE, a very faint bright line repre-
ﬂets. Panel C shows the SSFP image of a MVP patient with
el E shows the SSFP image of another MVP patient who does not
le leaﬂets. Panels D and F show the corresponding 3-dimensional
enhancement in the anterior leaﬂets (black arrows) and posteriora
in both patients. Abbreviations as in Figure 1.ave a best fit as CMR indexed leaflet length  4.1
m/m2  0.59  TTE indexed leaflet length, with
2  0.548, as shown in Figure 4B.
omparison of MADs. Both TTE and CMR found
hat MVP patients have greater MADs, as shown
n Table 3. The CMR measurements were greater
han TTE measurements for indexed major MAD
n both control patients and MVP patients (p 
.0001). Linear regression gave a best fit as CMR
ndexed MAD  2.7 mm/m2  0.99  TTE
ndexed MAD, with R2  0.547, as shown in
igure 5B.
GE in the mitral valve. The presence of LGE on the
alve and the mitral annulus was common in MVP
atients with 15 of 16 (94%) partial or complete
ing-shaped extensive LGEs on high-resolution 3D
GE-CMR imaging in the short axis view at the
alve plane (Fig. 6). Extensive LGE of the mitral
alve was not appreciated in control patients in the
hort axis valve plane with a representative example
hown in Figure 6B.
GE in the papillary muscles. Of the 19 prospectively
nrolled MVP patients with adequate 3D LGE-
MR images, 16 were included in the analysis.
yocardial LGE was present in the papillary mus-
les in 10 of 16 MVP patients (63%) as indicated by
D LGE-CMR, but 2D-LGE only identified 5 of
hose 10 (50%) patients (2 examples are shown in
ig. 7). There was no myocardial LGE found on
D or 3D LGE-CMR in control patients. No
Table 3. Mitral Valve Characteristics of
MVP and Control Patients by TTE and CMR
TTE CMR
Control
(n  25)
MVP
(n  25)
Control
(n  25)
MVP
(n  25)
Thickness
(A) (mm) 3.5 0.2 5.0 0.3* 3.0 0.1 3.2 0.2†
(P) (mm) 2.6 0.2 4.7 0.4* 2.3 0.1 3.2 0.1*
Indexed length
(A) (mm/m2) 14.3 0.6 15.6 0.6† 13.0 0.4 14.1 0.5†
(P) (mm/m2) 7.8 0.4 9.6 0.5* 7.1 0.3 10.5 0.5*
Indexed annulus
(L) (mm/m2) 18.3 0.4 22.2 0.5* 21.5 0.5 27.8 0.7*
(S) (mm/m2) 17.1 0.6 21.7 0.6* 17.8 0.6 22.90.7*
Blood-to-leaﬂet
contrast ratio
(A) NA NA 1.5 0.1 2.2 0.1*
(P) NA NA 1.3 0.1 2.4 0.2*
Values are mean  standard error of mean. *p  0.01 versus control. †p 
nonsigniﬁcant versus control.
A  anterior; L  major axis; NA  not applicable; P  posterior; S  minor
axis; TTE  transthoracic echocardiography; other abbreviations as in Tables
1 and 2.Figure 6. Mitral Valve
(A, B) Control subject
ment (LGE) images at
sents normal valve lea
thickened leaﬂets. Pan
have readily identiﬁab
LGE-CMR images withdditional myocardial LGE was observed in MVP
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301atients. We did not find significant difference in
ge, gender, EF, or MR grade in MVP patients
ith or without papillary muscle LGE (Table 4).
Arrhythmia history of these 16 patients showed
1 (69%) had either Holter monitor or loop mon-
tor studies in the previous 5 years. All 8 patients
ith Grade IIIa (couplets) and IIIb (nonsustained
entricular tachycardia) CVA had positive LGE in
apillary muscles. The remaining 3 patients with
ither no ventricular arrhythmia or a few isolated
entricular ectopic beats, but had no LGE on
apillary muscles. There was a significant associa-
ion between CVA and the presence of LGE in the
apillary muscles (p  0.007) (Table 5).
I S C U S S I O N
ardiovascular magnetic resonance imaging is widely
sed to quantify LV function and MR volume (8–
1,31,32) and recently has been used in imaging MVP
13), but CMR criterion for MVP is still lacking. In our
resent study, we applied TTE criteria for MVP to cine
MR images and found the criterion of 2 mm of mitral
eaflet excursion into the left atrium beyond the mitral
nnulus in the long-axis view to be an applicable criterion
n CMR. Using cine SSFP LVOT stack, we can identify
rolapse within each scallop of the mitral valve and thus
rovide detailed valvular morphology information for
urgical planning.
We found that MVP patients had thicker and
onger posterior leaflets and larger MADs on
Figure 7. Mitral Papillary Muscle LGE
(A to D) Short axis SSFP, two-dimensional (2D) LGE-CMR, and high-
at the mid-papillary muscle level. Arrows point to LGE. (E to H) Ima
image with (arrow) “partial loss” of papillary muscle from volume a
ﬁrming enhancement in the papillary muscle. Arrows point to LGEMR, with excellent correlation with TTE find-ngs, which are consistent with published results
20,33,34). We did not find significant differences
n the mitral anterior leaflet thickness or length in
VP and control patients by CMR imaging in our
ohort. In pathological studies, the reported average
ontrol leaflet thickness was 1 mm and the average
VP leaflet thickness was 2 mm (35). The normal
eaflet thickness is below the limit of spatial reso-
ution achieved in routine CMR clinical imaging.
artial volume averaging has a greater affect on
ormal leaflets because of the thinner leaflets that
ake border identification for leaflet thickness
easurements difficult. Unlike thickness measure-
ents, the blood-to-leaflet contrast ratio does not
epend on border identification and is readily mea-
lution three-dimensional (3D) LGE-CMR images of 1 MVP patient
from another MVP patient. (E) Short-axis SSFP. (F) A 2D LGE-CMR
ging. (G) A 3D LGE-CMR. (H) A 3D multiplanar reconstruction con-
e papillary muscle.
Table 4. Patient Characteristics for LGE
Control
(n  10)
MVP Patients
(n  16)
Age (yrs) 43.9 11.7 51.4 9.0
Male (%) 5 (50) 9 (56)
BSA (m2) 1.86 0.19 1.93 0.26
EF (%) 63.3 5.0 64.6 6.5
MR (median) 1 3
LGE (n  10) LGE (n
Age (yrs) 48.9 9.8 55.2
Male (%) 6 (60) 3 (5
EF (%) 65.0 7.1 64.0
MR (median) 3 3
Values are mean  standard deviation. *Student t test. †Wilcoxon rank sum tereso
ges
vera
in thp Value
0.12*
0.77†
0.49*
0.40*
0.001†
 6)
6.3 0.18*
0) 0.71†
5.9 0.55*
0.91†
st.
LGE  late gadolinium enhancement; other abbreviations as in Table 1.
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302ured using standard CMR analysis software. In
ddition to an increased leaflet-to-blood contrast
atio, we also found that the MVP leaflets were
requently enhanced (94% of patients) in LGE-
MR images. Both of these findings may reflect
he significantly expanded spongiosa layer with
roteoglycan in the myxomatous valves (35).
We have found that LGE in the papillary mus-
les is associated with CVAs. Signal enhancement
sually is present at the papillary muscle tips adja-
ent to the attachment of the chordae tendineae.
he LGE has not been previously reported in MVP
atients, which may be due to the challenge of
dentifying papillary fibrosis against a background
f blood signals with significant partial volume
veraging of blood and papillary muscles due to low
patial resolution in routine 2D LGE-CMR imag-
ng. The 3D LGE-CMR image has the advantage
f increased spatial resolution (nearly a 4-fold in-
rease as 3D LGE-CMR voxel size is 0.26 of the
D voxel size), particularly slice resolution (27,36),
hich is critical in the assessment of small regions
f interest such as the papillary muscles. Further-
ore, there was increased time delay between
ontrast injection and imaging for 3D LGE-CMR
Table 5. LGE and CVA in MVP Patients
LGE in
Papillary Muscle CVA (>III) Non-CVA (0, I) Total
Yes 8 2 10
No 0 6 6
Total 8 8 16
Using Fisher’s exact test, p  0.007 for papillary muscle LGE and CVA.
CVA  complex ventricular arrhythmia; other abbreviations as in Tables 1
and 4.ber view and independent echocardio- the mitral valve, wiith possibly increased signal difference between
lood and fibrosis (37).
tudy limitations. We had no anterior-leaflet-only
rolapse patients in our cohort, although the com-
osition of our patient cohort is not unique (38).
ne possible explanation for this is that we ex-
luded patients with aortic regurgitation, which
eems to be associated with anterior leaflet prolapse
19). To further confirm that the 2-mm criterion
hould be used in the definition of MVP in CMR,
 larger sample population and inclusion of patients
ith anterior-leaflet-only prolapse are necessary.
he study of LGE and its association with CVAs is
lso limited by its small sample size. The risk of
udden death can only be assessed in a much larger
atient cohort with long-term follow-up, which is
eyond the scope of our study.
O N C L U S I O N S
e have defined MVP in CMR by applying the
TE criterion—the excursion of any mitral leaflet
egment(s) beyond the mitral annular plane into the
eft atrium during ventricular systole by at least 2
m in the LVOT view. We have found that MVP
atients, as compared with patients without MVP,
ave increased blood-to-leaflet contrast ratios,
onger and thicker posterior leaflets, and enlarged
ADs by CMR. We also report that hyperen-
ancement of the papillary muscles on LGE-CMR
maging is present in a subgroup of MVP patients
ith complex ventricular arrhythmias.
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